NDC product
Diclofenac Sodium and Misoprostol
NDC 0591-0397 · Actavis Pharma, Inc.
Key facts
| Product NDC | 0591-0397 |
|---|---|
| Proprietary name | Diclofenac Sodium and Misoprostol |
| Nonproprietary name | Diclofenac Sodium and Misoprostol |
| Substances | DICLOFENAC SODIUM, MISOPROSTOL |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Labeler | Actavis Pharma, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA201089 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC] and 2 more |
| Marketing start | Nov 1, 2012 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: